Source:http://linkedlifedata.com/resource/pubmed/id/19161150
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2009-1-28
|
pubmed:abstractText |
Biobanks have been developed as a tool to better understand the genetic basis of disease by linking DNA samples to corresponding medical information. The broad scope of such projects presents a challenge to informed consent and participant understanding. To address this, 200 telephone interviews were conducted with participants in the NUgene Project, Northwestern University's biobank. Interviews included a modified version of the "quality of informed consent measure" (QuIC) and semi-structured questions which were analyzed thematically for 109 of the interviews. The QuIC, originally applied to cancer clinical trials, objectively assessed some of the components of informed consent for a biobank, and interview questions provided rich data to assist in interpreting participant understanding. The best understood domains included: the nature of the study, benefit to future patients, and the voluntary nature of participation. Lower knowledge scores included: potential risks and discomforts, experimental nature of the research, procedures in the event of study-related injury, and confidentiality issues. Qualitatively, confidentiality protections of the study were described as good by most (>50%). Although some cited concerns with employer (12%) or insurance discrimination (25%), most considered the risks to privacy low (25%) or none (approximately 60%). Only 10% of participants explicitly stated they had no expectation for personal benefit, and when asked whether they expected to be contacted with study results, respondents were split between having no expectation (39%), being hopeful for results (37%) and expecting to be contacted with results (12%). These findings are informative to those establishing and implementing biobanks, and to the IRBs reviewing such studies.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1552-4833
|
pubmed:author | |
pubmed:copyrightInfo |
(c) 2009 Wiley-Liss, Inc.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
149A
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
188-98
|
pubmed:dateRevised |
2009-4-17
|
pubmed:meshHeading |
pubmed-meshheading:19161150-Databases, Factual,
pubmed-meshheading:19161150-Databases, Nucleic Acid,
pubmed-meshheading:19161150-Ethics Committees, Research,
pubmed-meshheading:19161150-Genetic Predisposition to Disease,
pubmed-meshheading:19161150-Humans,
pubmed-meshheading:19161150-Informed Consent,
pubmed-meshheading:19161150-Interviews as Topic
|
pubmed:year |
2009
|
pubmed:articleTitle |
Assessing the understanding of biobank participants.
|
pubmed:affiliation |
Center for Genetic Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. kormond@stanford.edu
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.
|